Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL

Clinical trial NCT04206943 · UNKNOWN

Trial details

NCT number: NCT04206943
Sponsor: Acibadem University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Non Hodgkin Lymphoma

Start date: 2019-10-12
Primary completion: 2021-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.